Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Named Patient Program With Rotigotine Transdermal System

ClinicalTrials.gov ID: NCT01095484

Public ClinicalTrials.gov record NCT01095484. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 8:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The named patient program will allow investigators to supply rotigotine transdermal system to patients who have a documented medical necessity to receive treatment with the drug.

Study identification

NCT ID
NCT01095484
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
UCB Pharma
Industry
Enrollment
520 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2008
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Oct 19, 2014

2008 – 2012

United States locations

U.S. sites
51
U.S. states
21
U.S. cities
49
Facility City State ZIP Site status
088 Birmingham Alabama
082 Cullman Alabama
085 Fairhope Alabama
014 Huntsville Alabama
097 Gilbert Arizona
003 Phoenix Arizona
044 Phoenix Arizona
036 Berkeley California
024 Fountain Valley California
034 Irvine California
019 Los Angeles California
040 Orange California
076 Sunnyvale California
035 Fort Collins Colorado
027 Washington D.C. District of Columbia
070 Atlantis Florida
002 Boca Raton Florida
031 Clearwater Florida
028 Largo Florida
075 Ormond Beach Florida
022 St. Petersburg Florida
004 Tampa Florida
054 Weston Florida
030 Atlanta Georgia
041 Honolulu Hawaii
011 Peoria Illinois
025 Destrehan Louisiana
091 Clinton Township Michigan
001 Southfield Michigan
042 Warren Michigan
037 Ocean Springs Mississippi
016 West Plains Missouri
026 Lincoln Nebraska
086 Freehold New Jersey
062 Ridgewood New Jersey
018 Albany New York
066 Brooklyn New York
006 Patchogue New York
052 Charlotte North Carolina
093 Salisbury North Carolina
065 Albany Oregon
009 Salem Oregon
048 Austin Texas
072 Austin Texas
071 Dallas Texas
046 Houston Texas
005 Kirkland Washington
017 Olympia Washington
012 Spokane Washington
053 Tacoma Washington
056 Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01095484, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2014 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01095484 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →